Daratumumab was approved in this setting in November 2025. Does this mean we should automatically prescribe it to all high-risk patients?
An Interview with Professor Rajshekhar…
Daratumumab was approved in this setting in November 2025. Does this mean we should automatically prescribe it to all high-risk patients?